Israel Englander’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $32.6M | Buy |
84,300
+60,000
| +247% | +$22.3M | 0.01% | 1215 |
|
|
2026
Q1 | $7.11M | Sell |
24,300
-5,400
| -18% | -$1.77M | ﹤0.01% | 2550 |
|
|
2025
Q4 | $10.4M | Buy |
29,700
+11,300
| +61% | +$3.82M | ﹤0.01% | 2222 |
|
|
2025
Q3 | $5.95M | Buy |
18,400
+2,900
| +19% | +$902K | ﹤0.01% | 2963 |
|
|
2025
Q2 | $6.03M | Sell |
15,500
-11,300
| -42% | -$4.55M | ﹤0.01% | 2795 |
|
|
2025
Q1 | $11.7M | Sell |
26,800
-7,200
| -21% | -$2.89M | 0.01% | 2029 |
|
|
2024
Q4 | $12.5M | Sell |
34,000
-120,700
| -78% | -$50.5M | 0.01% | 1968 |
|
|
2024
Q3 | $80.4M | Buy |
154,700
+300
| +0.2% | +$160K | 0.04% | 548 |
|
|
2024
Q2 | $83.7M | Sell |
154,400
-8,200
| -5% | -$4.33M | 0.04% | 503 |
|
|
2024
Q1 | $84.3M | Buy |
162,600
+8,800
| +6% | +$4.38M | 0.04% | 545 |
|
|
2023
Q4 | $72.5M | Sell |
153,800
-72,800
| -32% | -$33.7M | 0.03% | 570 |
|
|
2023
Q3 | $98.7M | Buy |
226,600
+110,600
| +95% | +$50.2M | 0.05% | 380 |
|
|
2023
Q2 | $51.5M | Buy |
116,000
+30,200
| +35% | +$13.9M | 0.03% | 718 |
|
|
2023
Q1 | $39.5M | Sell |
85,800
-197,100
| -70% | -$93.8M | 0.02% | 848 |
|
|
2022
Q4 | $145M | Buy |
282,900
+29,300
| +12% | +$14.9M | 0.08% | 241 |
|
|
2022
Q3 | $115M | Buy |
253,600
+90,100
| +55% | +$43.1M | 0.07% | 272 |
|
|
2022
Q2 | $78.9M | Buy |
163,500
+18,200
| +13% | +$9M | 0.05% | 402 |
|
|
2022
Q1 | $71.4M | Buy |
145,300
+8,400
| +6% | +$3.84M | 0.04% | 493 |
|
|
2021
Q4 | $63.5M | Buy |
136,900
+97,900
| +251% | +$41.2M | 0.03% | 586 |
|
|
2021
Q3 | $14.5M | Buy |
39,000
+14,200
| +57% | +$5.4M | 0.01% | 1616 |
|
|
2021
Q2 | $9.47M | Buy |
24,800
+20,300
| +451% | +$7.76M | 0.01% | 1981 |
|
|
2021
Q1 | $1.61M | Buy |
4,500
+2,500
| +125% | +$804K | ﹤0.01% | 3736 |
|
|
2020
Q4 | $642K | Buy |
+2,000
| New | +$614K | ﹤0.01% | 4020 |
|
|
2020
Q3 | – | Sell |
-27,200
| Closed | -$7.15M | – | 4537 |
|
|
2020
Q2 | $7.15M | Buy |
27,200
+19,200
| +240% | +$5.12M | 0.01% | 1467 |
|
|
2020
Q1 | $1.82M | Buy |
8,000
+6,400
| +400% | +$1.74M | ﹤0.01% | 2092 |
|
|
2019
Q4 | $483K | Buy |
+1,600
| New | +$440K | ﹤0.01% | 3402 |
|
|
2019
Q3 | – | Sell |
-51,600
| Closed | -$14.6M | – | 4258 |
|
|
2019
Q2 | $14.6M | Buy |
+51,600
| New | +$14.1M | 0.02% | 988 |
|
|
2014
Q4 | – | Sell |
-1,800
| Closed | -$215K | – | 3996 |
|
|
2014
Q3 | $215K | Buy |
+1,800
| New | +$206K | ﹤0.01% | 3367 |
|
Other funds holding ELV
Israel Englander's ELV Position: Q2 2026 in Review
Israel Englander reduced its Elevance Health (ELV) stake by 21% in Q2 2026, selling an estimated $71.1M and leaving 727,561 shares worth $281M. The position accounts for 0.1% of the portfolio, ranked #154.
Israel Englander first reported a position in ELV in Q2 2013 and has held it in 50 quarters since. The position peaked at $431M in Q3 2023. 1,596 funds tracked by Wall St. Rank hold ELV as of Q2 2026.
- Israel Englander held 727,561 shares of Elevance Health worth $281M as of Q2 2026.
- Israel Englander sold 191,610 Elevance Health shares in Q2 2026, an estimated $71.1M.
- Elevance Health made up 0.1% of Israel Englander's portfolio in Q2 2026, its #154 holding.
- Israel Englander first reported a position in Elevance Health in Q2 2013 and has held it in 50 quarters since.
- Israel Englander's Elevance Health position peaked at $431M in Q3 2023.
- 1,596 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.
Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.